Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Meningioma × Tablets × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 5 Obesity 2 Leukemia, Myeloid, Acute 2 Head and Neck Neoplasms 2 Endometrial Neoplasms 2 Triple Negative Breast Neoplasms 1 Tracheal Diseases 1 TP53 Y220C Mutation 1 Squamous Cell Carcinoma of Head and Neck 1 Smoking 1 Small Cell Lung Carcinoma 1 Salivary Gland Neoplasms 1 Rectal Neoplasms 1 Pulmonary Disease, Chronic Obstructive 1 Polycystic Ovary Syndrome 1 Peripheral Nervous System Diseases 1 Pancreatic Neoplasms 1 Overweight 1 Neoplasms 1 Neoplasm Metastasis 1 Multiple Myeloma 1 Motor Activity 1 Mesothelioma 1 Meningioma 1 Lymphoma 1 Lung Neoplasms 1 Localized Prostate Cancer 1 Leukemia 1 Laryngeal Diseases 1 Inflammation 1

Interventions

Magnetic Resonance Spectroscopy 6 lutetium Lu 177 dotatate 5 Specimen Handling 4 Proton Therapy 3 Everolimus 3 pembrolizumab 2 gallium Ga 68 dotatate 2 Sunitinib 2 Radiosurgery 2 Protons 2 Observation 2 Hydroxyurea 2 Ga(III)-DOTATOC 2 Elasticity Imaging Techniques 2 Bevacizumab 2 trametinib 1 regorafenib 1 olaparib 1 fludarabine 1 dexamethasone acetate 1 dexamethasone 21-phosphate 1 cabozantinib 1 auricularum 1 apatinib 1 abemaciclib 1 X-Rays 1 Watchful Waiting 1 Thrombectomy 1 Tablets 1 Sodium Chloride 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06275919 2025-03-13

MIRAGE

Istituto Oncologico Veneto IRCCS

Phase 2 Recruiting

Meningioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡